We are live on ! Find out more
SAM

Senzar Asset Management Portfolio holdings

AUM $34.7M
1-Year Est. Return 0.56%
This Fund
S&P 500
This Quarter Est. Return
+14.96%
1 Year Est. Return
+0.56%
3 Year Est. Return
-0.75%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$410M
AUM Growth
+$69.1M
Cap. Flow
+$36M
Cap. Flow %
8.78%
Top 10 Hldgs %
64.9%
Holding
47
New
15
Increased
13
Reduced
5
Closed
14

Top Buys

Rank Stock Value
1
STJ
St Jude Medical
STJ
+$48.8M
2
KND
Kindred Healthcare
KND
+$33.2M
3
LLY icon
Eli Lilly
LLY
+$21.8M
4
LH icon
Labcorp
LH
+$20.2M
5
MDXG icon
MiMedx Group
MDXG
+$19.7M

Top Sells

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$26.1M
2
CYH icon
Community Health Systems
CYH
+$23.5M
3
BHC icon
Bausch Health
BHC
+$21.5M
4
AGN
Allergan plc
AGN
+$18.4M
5
BIIB icon
Biogen
BIIB
+$12.8M

Sector Composition

Rank Sector Weight
1 Healthcare 83.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TLPH icon
26
Talphera
TLPH
$68M
$4.02M 0.98%
52,034
+6,695
+15% +$876K
ITCI
27
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$3.58M 0.87%
+150,100
New +$3.36M
VXRT
28
DELISTED
Vaxart
VXRT
$3.38M 0.82%
133,755
+5,782
+5% +$159K
ACHN
29
DELISTED
Achillion Pharmaceuticals
ACHN
$3.06M 0.74%
+309,900
New +$3.87M
RPRX
30
DELISTED
Repros Therapeutics Inc.
RPRX
$2.1M 0.51%
244,006
-520,400
-68% -$4.65M
ADYX
31
DELISTED
Adynxx Inc
ADYX
$1.37M 0.33%
+4,383
New +$1.43M
XENT
32
DELISTED
Intersect ENT, Inc
XENT
$1.11M 0.27%
+42,927
New +$982K
PFNX
33
DELISTED
Pfenex Inc.
PFNX
$834K 0.2%
+52,300
New +$576K
BHC icon
34
Bausch Health
BHC
$1.75B
– –
-150,300
Closed -$21.5M
BIIB icon
35
Biogen
BIIB
$30.9B
– –
-37,800
Closed -$12.8M
BLUE
36
DELISTED
bluebird bio
BLUE
– –
-2,910
Closed -$3.46M
CNMD icon
37
CONMED
CNMD
$1.3B
– –
-248,900
Closed -$11.2M
CYH icon
38
Community Health Systems
CYH
$382M
– –
-526,471
Closed -$23.5M
IRWD icon
39
Ironwood Pharmaceuticals
IRWD
$586M
– –
-933,469
Closed -$12M
VTRS icon
40
Viatris
VTRS
$20.8B
– –
-463,300
Closed -$26.1M
ICPT
41
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-61,900
Closed -$9.66M
MGLN
42
DELISTED
Magellan Health Services, Inc.
MGLN
– –
-208,500
Closed -$12.5M
FPRX
43
DELISTED
Five Prime Therapeutics, Inc.
FPRX
– –
-332,474
Closed -$8.98M
AGN
44
DELISTED
Allergan plc
AGN
– –
-71,600
Closed -$18.4M
SLXP
45
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
– –
-85,400
Closed -$9.82M
COV
46
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
– –
-105,862
Closed -$10.8M
MDVN
47
DELISTED
MEDIVATION, INC.
MDVN
– –
-159,000
Closed -$7.92M
1
2

Similar funds

BCP
Blum Capital Partners San Francisco, California $34.1M AUM 1.14% 1-Year Est. Return
PRHC
P.R. Herzig & Co Roslyn Heights, New York $45.9M AUM 15.88% 1-Year Est. Return
NAM
Needelman Asset Management Ladera Ranch, California $46M AUM 8.27% 1-Year Est. Return
GG
Gores Group Beverly Hills, California $22.3M AUM 4.58% 1-Year Est. Return
SM
SLS Management New York $17.2M AUM 14.82% 1-Year Est. Return
BC
Breogan Capital New York $56.4M AUM
SCPM
Social Capital PEP Management Palo Alto, California $56.5M AUM
FAM
Fortaleza Asset Management Chicago, Illinois $12.3M AUM 48.33% 1-Year Est. Return

Senzar Asset Management's Q1 2015 Portfolio in Review

As of Q1 2015, Senzar Asset Management held 47 positions worth $410M, up 20% from $341M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Senzar Asset Management deployed $36M of net new capital in Q1 2015, opening 15 new positions and adding to 13 existing holdings. Its largest new stake was St Jude Medical: 733,600 shares worth $48M.

By sector, the portfolio is most concentrated in Healthcare at 83% of assets, down from 86% a quarter earlier.

On the sell side, the largest reduction was Sanofi, an estimated $10.8M trimmed.

  • Senzar Asset Management's largest Q1 2015 buy was St Jude Medical: 733,600 shares worth $48M.
  • Senzar Asset Management added most to Teva Pharmaceuticals in Q1 2015, an estimated $18.6M increase.
  • Senzar Asset Management's biggest Q1 2015 reduction was Sanofi, cutting an estimated $10.8M.
  • Senzar Asset Management fully exited Viatris in Q1 2015, selling an estimated $26.1M.
  • Senzar Asset Management's ten largest holdings make up 65% of its $410M portfolio in Q1 2015.
  • Senzar Asset Management opened 15 new positions and closed 14 in Q1 2015.
  • Senzar Asset Management's portfolio value rose 20% quarter-over-quarter to $410M.

Based on Senzar Asset Management's 13F filing for Q1 2015, filed 15 May 2015.